Related Experiment Video
Updated: Apr 13, 2026

Instrumentation of Near-term Fetal Sheep for Multivariate Chronic Non-anesthetized Recordings
Published on: October 25, 2015
Prenatal dexamethasone-induced programmed hypertension and renal programming
Jiunn-Ming Sheen1, Hong-Ren Yu1, Mao-Meng Tiao1
1Department of Pediatrics, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University, College of Medicine, Kaohsiung, Taiwan.
Insights
Prenatal dexamethasone (DEX) exposure in rats alters kidney gene expression, leading to programmed hypertension. Key genes in arachidonic acid metabolism and factors regulating blood pressure contribute to this condition.
Area of Science:
- Developmental programming
- Renal physiology
- Endocrinology
Background:
- Antenatal glucocorticoids can cause long-term health issues in offspring, including hypertension.
- Prenatal dexamethasone (DEX) exposure is a known model for programmed hypertension.
- The precise mechanisms of renal programming and DEX's impact on hypertension development are not fully understood.
Purpose of the Study:
- To investigate the effects of prenatal DEX exposure on the renal transcriptome at different developmental stages.
- To identify key genes and pathways involved in DEX-induced renal programming and hypertension.
- To explore the relationship between DEX, programmed hypertension, and blood pressure regulatory factors.
Main Methods:
- Pregnant rats were administered intraperitoneal dexamethasone (DEX) during late gestation (gestational days 16-22).
- RNA next-generation sequencing (NGS) was used to analyze the renal transcriptome of male offspring.
- Programmed hypertension in male offspring was assessed at 16 weeks of age.
Main Results:
- Prenatal DEX consistently altered 431 renal transcripts from nephrogenesis through adulthood.
- Differentially expressed genes related to blood pressure regulation were identified at pre-hypertensive (11 genes) and established hypertension (13 genes) stages.
- Genes involved in arachidonic acid metabolism and endothelium-derived hyperpolarizing/contractile factors (EDHF/EDCF), such as Ephx2, were implicated.
Conclusions:
- Prenatal DEX exposure disrupts the balance of EDHFs and EDCFs, potentially causing renal programming and hypertension.
- The arachidonic acid metabolism pathway appears to be a significant contributor to programmed hypertension.
- Identified genes and pathways offer potential therapeutic targets for preventing corticosteroid-induced programmed hypertension.
Aims:
Antenatal glucocorticoids can induce long-term effects on offspring health, including hypertension. Programmed hypertension has been observed in a prenatal dexamethasone (DEX) exposure model. However, how renal programming responds to prenatal DEX at different stages of development and the impact of DEX on programmed hypertension remain unclear. Therefore, we utilized RNA next-generation sequencing (NGS) to analyze the renal transcriptome in the offspring to examine whether key genes and pathways are responsible for DEX-induced renal programming and hypertension.
Main Methods:
Pregnant rats received intraperitoneal dexamethasone from gestational day 16 to 22. Prenatal DEX-induced programmed hypertension was examined in male offspring at 16 weeks of age.
Key Findings:
Prenatal DEX modified 431 renal transcripts from the nephrogenesis stage to adulthood in a constant manner. At the pre-hypertensive and established hypertension stages, we identified 11 and 13 differentially expressed genes related to blood pressure regulation, respectively. Among these genes, Npr3, Ptgs2, Agt, Edn3, Ephx2, Agtr1b, and Gucy1a3 are associated with endothelium-derived hyperpolarizing and contractile factors (EDHF and EDCF). Genes in the arachidonic acid metabolism pathway may potentially be key genes contributing to programmed hypertension. In addition, DEX induced soluble epoxide hydrolase expression (Ephx2 gene encoding protein).
Significance:
Prenatal DEX elicits an imbalance between EDHFs and EDCFs that might lead to renal programming and hypertension. The arachidonic acid metabolism pathway is a common pathway contributing to programmed hypertension. Our results highlight candidate genes and pathways involved in renal programming as targets for therapeutic approaches to prevent programmed hypertension in children exposed to antenatal corticosteroids.
More Related Videos
07:36Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
05:31Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
Published on: January 26, 2024
Related Concept Videos
Hormonal Regulation
Teratogenicity
Antihypertensive Drugs: Potassium-Sparing Diuretics
Hypertension II: Pathophysiology
Hypertension and Regulation of Blood Pressure
Renal Tubule and Collecting Duct
Proximal Convoluted Tubule (PCT):
The PCT is the initial segment of the renal tubule, extending from the Bowman's capsule that encloses the glomerulus. Its convoluted structure and microvilli-lined cells increase the surface area for reabsorption. The PCT reabsorbs glucose, amino acids, sodium, and water from the filtrate, ensuring essential...